Peng, Wenying
Li, Bin
Li, Jin
Chang, Lianpeng
Bai, Jing
Yi, Yuting
Chen, Rongrong
Zhang, Yanyan
Chen, Chen
Pu, Xingxiang
Jiang, Meilin
Li, Jia
Zhong, Rui
Xu, Fang
Chen, Bolin
Xu, Li
Wang, Ning
Huan, Jiaojiao
Dai, Pingping
Guan, Yanfang
Yang, Ling
Xia, Xuefeng
Yi, Xin
Wang, Jiayin
Yu, Fenglei http://orcid.org/0000-0003-3409-065X
Article History
Received: 12 December 2019
Accepted: 8 February 2022
First Online: 10 March 2022
Competing interests
: L.W. reports personal fees from AstraZeneca, Roche, Bristol-Myers Squibb, MSD, Pfizer, Lilly, Boehringer Ingelheim, Merck, Innovent and Hengrui outside the submitted work. J.B., Y.Y., R.C., Y.Z.,C.C., Jin L., J.H., P.D., Y.G., L.C., L.Y., and X.Y are current employees of Geneplus-Beijing. The remaining authors declare no competing interests.